昭衍新药
(603127)
| 流通市值：204.99亿 | | | 总市值：243.69亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-06-12 | 2291.83万 | 3.74% | 289.10万 | 0.47% | -730.43万 | -1.19% | -1850.51万 | -3.02% |
| 2026-06-11 | -348.46万 | -0.80% | 487.74万 | 1.13% | -2355.04万 | -5.44% | 2215.76万 | 5.12% |
| 2026-06-10 | 758.92万 | 1.63% | 2690.26万 | 5.77% | 792.84万 | 1.70% | -4242.02万 | -9.09% |
| 2026-06-09 | -1432.93万 | -3.44% | -1329.21万 | -3.20% | -1208.52万 | -2.91% | 3970.66万 | 9.54% |
| 2026-06-08 | -2271.71万 | -4.42% | -3142.80万 | -6.12% | -5358.25万 | -10.43% | 10772.76万 | 20.97% |
| 2026-06-05 | -635.59万 | -0.89% | 766.67万 | 1.07% | -633.84万 | -0.88% | 502.75万 | 0.70% |
| 2026-06-04 | 427.81万 | 1.08% | -447.99万 | -1.13% | -432.78万 | -1.10% | 452.96万 | 1.15% |
| 2026-06-03 | 176.07万 | 0.27% | 1425.25万 | 2.18% | 2681.67万 | 4.11% | -4283.00万 | -6.56% |
| 2026-06-02 | -5012.60万 | -7.56% | -2434.60万 | -3.67% | -4940.73万 | -7.45% | 12387.92万 | 18.67% |
| 2026-06-01 | -4676.45万 | -4.88% | -5877.13万 | -6.13% | -8671.61万 | -9.04% | 19225.19万 | 20.05% |